Literature DB >> 3033079

Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.

J Buck, U Hämmerling, M K Hoffmann, E Levi, K Welte.   

Abstract

Autocrine growth factor for Epstein-Barr virus-transformed human B cells (aBGF), a protein that is constitutively produced by the human EBV-transformed B cell line 5/2, has been purified from serum-free conditioned medium. The purification involved sequential ammonium sulfate precipitation, ion exchange chromatography, gel filtration, and reversed-phase high performance liquid chromatography. The purified protein has a m.w. of 16,000 in NaDodSO4/polyacrylamide gel electrophoresis and an isoelectric point between 7.0 and 8.0. The relative molecular mass 16,000 form exists in equilibrium with dimeric and tetrameric forms. aBGF supports the growth of EBV-transformed B cells, which have been deprived of their own conditioned medium. The purified aBGF is fully effective at 0.5 ng/ml and has no interleukin 1 activity in the lymphocyte activation factor assay. Because several randomly selected lines of EBV-transformed cells and one EBV-negative lymphoma cell line both produce aBGF activity and show growth dependency on aBGF and because stimulation of normal B cells with anti-immunoglobulin M is increased by aBGF, we propose that aBGF has general significance for growth control of human B cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033079

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Activity of soluble factors produced by Epstein-Barr virus-transformed human B lymphocytes on different cell lines.

Authors:  C Garzelli; A Bazzichi
Journal:  Experientia       Date:  1991-07-15

2.  Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.

Authors:  Y L Lau; J G Shields; R J Levinsky; R E Callard
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1.

Authors:  B A Blazar; A M Murphy
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

4.  Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.

Authors:  M Birkenbach; D Liebowitz; F Wang; J Sample; E Kieff
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor.

Authors:  J Morgan; A Roome; A Maizel; S Sharma
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

6.  Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.

Authors:  P S Randhawa; A Zeevi; C Alvares; S Gollin; R Agostini; E Yunis; S Saidman; L Contis; A J Demetris; M A Nalesnik
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

7.  A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.

Authors:  O Devergne; M Hummel; H Koeppen; M M Le Beau; E C Nathanson; E Kieff; M Birkenbach
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).

Authors:  R E Callard; Y L Lau; J G Shields; S H Smith; J Cairns; L Flores-Romo; J Gordon
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

9.  Retinol is essential for growth of activated human B cells.

Authors:  J Buck; G Ritter; L Dannecker; V Katta; S L Cohen; B T Chait; U Hämmerling
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.

Authors:  S S Sung; L K Jung; J A Walters; W Chen; C Y Wang; S M Fu
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.